Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol in Ozone Pollution for EIB
NCT05087693Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Nov 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol in asthma, Exercise-induced bronchoconstriction (EIB), sponsored by University of British Columbia. Started Nov 2021; status: completed.
02
Drugs
salbutamol
03
Conditions
asthmaExercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT05087693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087693.